Gala Pharmaceutical Inc.: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2018)
- $4.7K
- Net Income/Loss (FY2018)
- -$1.9M
- Total Assets (FY2018)
- $262.2K
- Total Equity (FY2018)
- -$858.7K
- Cash Flows from Operating Activities (FY2018)
- -$631.9K
Source: Gala Pharmaceutical Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
